课题基金 / 基金详情

The mechanism of escape from hypoxia-induced apoptosis in squamous cell carcinoma cells.

The mechanism of escape from hypoxia-induced apoptosis in squamous cell carcinoma cells.
鳞状细胞癌细胞逃避缺氧诱导的细胞凋亡的机制。
批准号:
16390538
负责人:
YAMAMOTO Tetsuya
金额:
$9.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

YAMAMOTO Tetsuya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The transcription factor hypoxia-inducible factor 1(HIF-1) plays an important role in solid tumor cell growth and survival. Over-expression of HIF-1α has been demonstrated in many human tumors and predicts a poor response to chemoradiotherapy. We examined the HIF-1α-induced survival pathways and the influence of HIF-1α on the susceptibility to chemotherapeutic drugs and γ-rays in human oral squamous cell carcinoma cell (OSCC) lines. The results showed that forced expression of HIF-1α suppressed hypoxia-induced apoptosis of OSCC lines by inhibiting cytochrome c release from mitochondria. Over-expression of HIF-1α inhibited the generation of reactive oxygen species (ROS), elevation of intracellular Ca^<2+> concentration, reduction of mitochondrial membrane potential, and cytosolic accumulation of cytochrome c, which resulted in the inactivation of caspase-9 and caspase-3. In addition, anti-apoptotic Bcl-2 and Bcl-X_L levels were increased and pro-apoptotic Bax and Bak levels were decreas … More ed in the HIF-1α-overexpressing OSCC line. Over-expression of HIF-1α also increased the levels of phosphorylation of Akt and extracellular signal-regulated kinases (ERK). These findings indicate that HIF-1α prevents apoptotic cell death through two mechanisms including inhibition of cytochrome c release and activation of Akt and ERK. Treatment with chemotherapeutic drugs and γ-rays enhanced the expression and nuclear translocation of HIF-1α and the susceptibility of OSCC cells to the drugs and γ-rays was negatively correlated with the expression level of HIF-1α protein. The over-expression of HIF-1α induced OSCC cells more resistant to the anticancer agents and the down-regulation of HIF-1α expression by small interfering RNA enhanced the susceptibility of OSCC cells to them. In the HIF-1α-knockdown OSCC cells, the expression of P-glycoprotein, heme oxygenase-1, manganese-superoxide dismutase and ceruloplasmin were down-regulated and the intracellular levels of chemotherapeutic drugs and reactive oxygen species were sustained at higher levels after the treatment with the anticancer agents. These results suggest that down-regulation of HIF-1α expression is an effective strategy for cancer treatment. Less
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DNA identification of the pathogen of candidal aspiration pneumonia induced in the course of oral cancer therapy
口腔癌治疗过程中诱发念珠菌吸入性肺炎病原菌的DNA鉴定
DOI: --
发表时间: 2005
期刊: J Med Microbiol 54・Pt5
影响因子: --
作者: [Tsuchimoto.Y., Yoshida, Y.et al., Yamamoto T]
通讯作者: Yamamoto T
DOI: 10.1124/jpet.105.090399
发表时间: 2005-11-01
期刊: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
影响因子: 3.5
作者: [Hsu, S, Dickinson, DP, Schuster, G]
通讯作者: Schuster, G
DOI: --
发表时间: 2006
期刊: Shikoku Dental Research 18(2)
影响因子: --
作者: [Marianel Trujillo-Lemon, Junhao Ge, Hui Lu, Jiro Tanaka, Jefery W.Stansbury, Marianela Trujillo-Lemon, Yamamoto T]
通讯作者: Yamamoto T
DOI: 10.1111/j.1349-7006.2005.00065.x
发表时间: 2005-07-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Sasabe, E, Tatemoto, Y, Osaki, T]
通讯作者: Osaki, T
6
    Establishment of a novel therapy for glioblastoma with Alternative Magnetic Fields
    • 批准号:
      20K09396
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2020
    • 负责人:
      YAMAMOTO Tetsuya
    • 依托单位:
    Development of neurocognitive interventions for prevention of relapse/recurrence in major depressive disorder
    • 批准号:
      18K13323
    • 项目类别:
      Grant-in-Aid for Early-Career Scientists
    • 资助金额:
      $2.66万
    • 财政年份:
      2018
    • 负责人:
      YAMAMOTO Tetsuya
    • 依托单位:
    Amino Acid Pre-loading for Boron Neutron Capture Therapy
    • 批准号:
      26462198
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2014
    • 负责人:
      YAMAMOTO Tetsuya
    • 依托单位:
    Quantitative nondestructive evaluation using ultrasonic wave visualization technique for structural health monitoring
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: